2-(4-morpholinyl)cyclohexanone 、 Bredereck 试剂 以to give crude title compound (260 mg) as a yellow oil which的产率得到2-[1-dimethylaminomethylidene]-6-morpholin-4-ylcyclohexanone
The invention relates to compounds of formula
wherein R1, R2, R3, R4, X and Y are as defined herein and to pharmaceutically active acid addition salts thereof. The compounds can be used for the treatment of Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica or Down syndrome.